The World Health Organization (WHO) has approved Oxford-AstraZeneca’s COVID-19 Vaccine for emergency use. With the approval of the vaccine, the WHO program to provide vaccines to poor countries will now accelerate. WHO has approved the vaccine to be made in South Korea at AstraZeneca-SKBio and Serum Institute of India.
After approving the vaccine, the WHO said that countries which do not have the vaccine now, will be able to give vaccines to their health workers and the public.
The vaccines of Oxford University and British-Swedish pharma company AstraZeneca are being manufactured at the Serum Institute of India in Pune, India. In India, it is being sold under the name ‘Covishield‘. The Indian government had approved this vaccine for emergency use in the month of January.
SAGE recommended vaccine
The WHO expert panel, the Strategic Advisory Group of Experts (SAGE), recommended the use of the vaccine. The panel had said that the vaccine is right for people of all ages. The panel has said in its recommendation that the vaccine should be given in two doses, and there should be a difference of between 8 and 12 weeks.